Interleukin-1 Stimulates the Secretion of Hypothalamic Corticotropin-Releasing Factor
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
There is now evidence that the immune system, during times of infectious challenge, can stimulate the secretion of glucocorticoids, the adrenal steroids that mediate important aspects of the response to stress. Specifically, secretion of interleukin-1 (IL-1), a monocyte lymphokine secreted after infection, appears at least in part responsible for this effect. Glucocorticoids are secreted in response to a neuroendocrine cascade involving, first, the brain, then the pituitary, and finally the adrenal gland. In this report, human IL-1 is shown to activate the adrenocortical axis at the level of the brain, stimulating the release of the controlling hormone corticotropin-releasing factor (CRF) from the hypothalamus. Infusion of IL-1 induced a significant secretion of CRF into the circulation exiting the hypothalamus, whereas immunoneutralization of CRF blocked the stimulatory effect of IL-1 on glucocorticoid secretion. IL-1 appeared to have no acute direct stimulatory effects on the pituitary or adrenal components of this system. Furthermore, IL-1 did not cause a nonspecific release of other hypothalamic hormones. Thus, the lymphokine acts in a specific manner to activate the adrenocortical axis at the level of the brain; this effect appears to be unrelated to the known pyrogenic effects of IL-1 within the hypothalamus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta exhibited the ability to activate the HPA axis and suppress the hypothalamic–pituitary–gonadal (HPG) axis [111,112,113].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [112]
In the citing paper
“Under normal conditions, activation of the HPA axis suppresses (rather than promotes) transcription of both proinflammatory and antiviral immune response genes by stimulating the release of one of the body's most potent anti-inflammatory substances, the glucocorticoid cortisol, from the adrenal cortex”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Sapolsky, Rivier, Yamamoto, Plotsky, & Vale, 1987
In the citing paper
“IL-1 was the first cytokine clearly shown to have a direct action on the HPAA at the level of either the pituitary (34) or the hypothalamus (35,36).”
From Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice (2003) · cites this paper as [35]
Citations
Cites
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965
Corticosteroid‐Mediated Immunoregulation in Man
Cupps, T. R., & Fauci, A. S. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb00431.x · Cited by 887
ANTONI, F. A. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-351 · Cited by 883
VALE, W., VAUGHAN, J., SMITH, M., & YAMAMOTO, G. (1983) · Endocrinology · doi:10.1210/endo-113-3-1121 · Cited by 563
Self-citationRIVIER, C., BROWNSTEIN, M., SPIESS, J., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-110-1-272 · Cited by 555
Self-citationRivier, C., & Vale, W. (1983) · Nature · doi:10.1038/305325a0 · Cited by 539
Self-citationCorticotropin-Releasing Activity of Monokines
Woloski, B. M. R. N. J., Smith, E. M., Meyer, W. J., Fuller, G. M., & Blalock, J. E. (1985) · Science · doi:10.1126/science.2997929 · Cited by 486
Research works printed but not linked: 4
- KRUEGER, J.M., SLEEP-PROMOTING EFFECTS OF ENDOGENOUS PYROGEN (INTERLEUKIN-1), AMERICAN JOURNAL OF PHYSIOLOGY 246: R994 (1984).
- MCGILLIS J THESIS G WASHINGTON (1985).
- PLOTSKY, P, ENDOCRINOLOGY 114: 939 (1984).
- TORRESALEMAN, J, LIFE SCI 30: 929 (1987).
Cited by
Items 901–1,000 of 1,004
Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
Wang, C., Zhou, Y., & Feinstein, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106005 · Cited by 22
“In fact, pro-inflammatory cytokines, in particular IL-1, are potent activators of the HPA axis, where they stimulate corticotropinreleasing factor (CRF) production from the hypothalamus to promote corticosteroid productions (Sapolsky et al., 1987).”
BackgroundMalcher‐Lopes, R., & Buzzi, M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81011-x · Cited by 25
Endometrial Corticotropin‐Releasing Hormone: Its Potential Autocrine and Paracrine Actionsa
Zoumakis, E., Makrigiannakis, A., Margioris, A. N., Stournaras, C., & Gravanis, A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48525.x · Cited by 24
Kolasa, M., Faron‐Górecka, A., Kuśmider, M., Szafran‐Pilch, K., Solich, J., Żurawek, D., Gruca, P., Papp, M., & Dziedzicka‐Wasylewska, M. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.008 · Cited by 20
The role of cytokines in the normal and neoplastic pituitary
Tsagarakis, S., Kontogeorgos, G., & Kovacs, K. (1998) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00005-5 · Cited by 20
Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms.
Schwarz, M. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.2/mschwarz · Cited by 21
Mechanisms of interleukin-1-induced hormone secretion from the rat adrenal gland.
Gwosdow, A. R. (1995) · Endocrine Research · doi:10.3109/07435809509030418 · Cited by 19
Metabolic and Endocrine Actions of Interleukin‐1. Effects on Insulin‐Resistant Animalsa
Besedovsky, H. O., & del Rey, A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb40481.x · Cited by 19
Lotem, J., & Sachs, L. (1988) · Blood · doi:10.1182/blood.v72.5.1595.1595 · Cited by 19
Juanéda, C., Dubourg, P., Ciofi, P., Sarrieau, A., Corio, M., & Tramu, G. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00133-5 · Cited by 19
Reincke, M., LEHMANN, R., Karl, M., MAGIAKOU, A., Chrousos, G. P., & Allolio, B. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44710.x · Cited by 21
Contrasting Effects of Specific Lymphokines on the Survival of Hippocampal Neurons in Culture
Araujo, D. M. (1992) · Advances in behavioral biology · doi:10.1007/978-1-4615-3432-7_9 · Cited by 19
Interleukin‐1 in the Noradrenergic Chromaffin Cells in the Rat Adrenal Medulla
Bartfai, T., ANDERSSON, C., Bristulf, J., Schultzberg, M., & Svenson, S. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb40480.x · Cited by 19
Richey, L., Doremus‐Fitzwater, T. L., Buck, H. M., & Deak, T. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.004 · Cited by 19
“Mechanistically, several different pathways are seemingly responsible for communicating peripheral cytokine signals to the brain (for review see Dantzer, 2009), resulting in increased expression of pro-inflammatory cytokines within the CNS (e.g., Rivest and Rivier, 1991; Sapolsky et al., 1987).”
BackgroundLi, T., Koshy, S., & Folkesson, H. G. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90506.2008 · Cited by 20
“We (37) and others (28) have demonstrated that IL-1 can activate the HPA axis, ultimately leading to adrenal cortisol synthesis and secretion.”
BackgroundIs there an immunologic basis for schizophrenia?
Leonard, B. E. (2005) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.1.1.103 · Cited by 18
Immunomodulatory role of the corticotropin-releasing factor.
Radulović, M., & Spiess, J. (2001) · PubMed · Cited by 18
Engström, L., Engblom, D., & Blomqvist, A. G. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10770 · Cited by 18
“Other possible factors that could influence ppENK transcription are glucocorticoids that are rapidly released from the adrenal glands after immune challenge (Sapolsky et al., 1987).”
BackgroundSignificance of chorioamnionitis
Kitajima, H., Nakayama, M., Miyano, A., Shimizu, A., Taniguchi, T., Shimoya, N., Matsuzaki, N., & Fujimura, M. (1992) · Early Human Development · doi:10.1016/0378-3782(92)90126-2 · Cited by 18
Ohgo, S., NAKATSURU, K., Ishikawa, E., & Matsukura, S. (1991) · Brain Research · doi:10.1016/0006-8993(91)90771-m · Cited by 18
Liu, D.-H., Su, Y., Zhang, W., Lou, S.-F., Ran, X., Gao, J.-S., & Cheng, T. (2002) · Burns · doi:10.1016/s0305-4179(02)00011-6 · Cited by 19
Daun, J. M., Ball, R. W., & Cannon, J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.4.r855 · Cited by 18
Day, H. E. W., & Akil (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00358.x · Cited by 18
Thymic regulation of the hypothalamic-pituitary-gonadal axis
HALL, N. R. S., O’Grady, M. P., & Menzies, R. A. (1992) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(92)90164-g · Cited by 18
A Novel Endogenous Corticotropin Release Inhibiting Factor
Redei, E. E., Rittenhouse, P. A., Revskoy, S., McGivern, R. F., & Aird, F. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09584.x · Cited by 18
Marchetti, B., Peiffer, A. P., Morale, M. C., Batticane, N., GALLO, F., & Barden, N. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56839.x · Cited by 18
Takao, T., Dieterich, K. D., Tracey, D. E., & Souza, E. B. D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91381-1 · Cited by 18
Gomez, A. M., Wu, Y., Zhang, C., Boyd, L., Wee, T.-L., Gewolb, J., Amor, C., Cheadle, L., & Borniger, J. C. (2025) · Neuron · doi:10.1016/j.neuron.2025.11.019 · Cited by 22
Activation of chronic toxoplasmosis by transportation stress in a mouse model
Shen, B., Yuan, Y., Cheng, J., Pan, M., Xia, N., Zhang, W., Wang, Y., Zhou, Y., & Zhao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.13568 · Cited by 17
Bhavya, S., Lew, P. S., & Mizuno, T. M. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.01.007 · Cited by 17
Hypothalamic Inflammation at a Crossroad of Somatic Diseases
Mravec, B., Horváthová, Ľ., & Černáčková, A. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0631-4 · Cited by 18
Glucocorticoids and the immune response
Wiegers, G. J., Stec, I. E. M., Sterzer, P., & Reul, J. M. H. M. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80055-0 · Cited by 29
Crane, J. W., & Buller, K. M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.07.012 · Cited by 17
Cortisol levels are associated with mortality risk in hemodialysis patients
Gracia-Iguacel, C., González‐Parra, E., Egido, J., Lindholm, B., Mahíllo, I., Carrero, J. J., & Ortíz, A. (2014) · Clinical Nephrology · doi:10.5414/cn108311 · Cited by 19
“ACTH and cortisol were found to be elevated, for example, after intravenous administration of IL-1 [45] or IL-6 [46, 47].”
BackgroundResponse of Interleukin‐1β in the Magnocellular System to Salt‐Loading
Summy‐Long, J. Y., Hu, S., Pruss, A., Chen, X., & Phillips, T. M. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01490.x · Cited by 19
Ekimova, I. V. (2003) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1023459100213 · Cited by 17
“It is interesting to note that endotoxin fever suppressed the processes of neurosecretion in magnocellular vasopressinergic neurons but increased these processes in parvocellular neurons containing corticotropin-releasing factor [24, 25].”
BackgroundLaflamme, N., Barden, N., & Rivest, S. (1997) · Journal of Molecular Neuroscience · doi:10.1007/bf02736831 · Cited by 17
Endocrine Aspects of Neuroimmunomodulation: Methods and Overview
McCann, S. M., Milenković, L., González, M. C., Lyson, K., Karanth, S., & Rettori, V. (1993) · Methods in neurosciences · doi:10.1016/b978-0-12-185281-8.50017-x · Cited by 17
Lee, S., & RIVIER, C. L. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00072.x · Cited by 18
Self-citationA Candidate Case for Lymphocytic Infundibulo-Neurohypophysitis Mimicking a Neurohypophysial Tumor.
Tsujii, S., Takeuchi, J., Koh, M., MIZUTA, M., Azuma, Y., Oishi, M., Akazawa, Y., & Kuzuya, H. (1997) · Internal Medicine · doi:10.2169/internalmedicine.36.293 · Cited by 17
Regulation of pro-opiomelanocortin biosynthesis and processing by transplantation immunity
Zakarian, S., Eleazar, M. S., & Silvers, W. K. (1989) · Nature · doi:10.1038/339553a0 · Cited by 17
Földes, A., Némethy, Z., Szalay, O., & Kovács, K. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00299-9 · Cited by 17
6 Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infection
Nunez, E. A., & Christeff, N. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80302-7 · Cited by 17
Pournajafi‐Nazarloo, H., Takao, T., Taguchi, T., Ito, H., & Hashimoto, K. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00176-0 · Cited by 22
Kasckow, J., Han, J., Parkes, D. G., MULCHAHEY, J. J., Owens, M. J., Risby, E. D., Fisher, J. M., & Nemeroff, C. B. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00782.x · Cited by 17
“Compounds that regulate both CNS and placental neurons include forskolin, norepinephrine, serotonin, acetylcholine and interleukin 1 (9-14).”
BackgroundEffect of interleukin 1 beta on transducing mechanisms in 235-1 clonal pituitary cells
Schettini, G., Florio, T., Meucci, O., Scala, G., Landolfi, E., & GRIMALDI, M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81252-x · Cited by 17
Thymic stromal elements contain an anterior pituitary hormone-stimulating activity
Spangelo, B. L., Ross, P. C., Judd, A. M., & MacLeod, R. M. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90084-2 · Cited by 17
“Interleukin-1 (IL-1), for example, appears to cause the release of glucocorticoids (Besedovsky et al., 1986; Sapolsky et al., 1987) through increases in hypothalamic corticotropin (CRF) (Sapolsky et al., 1987; Uehara et al., 1987).”
BackgroundNeuroimmune axis as a basis of therapy in Alzheimer’s disease
Singh, V. K. (1990) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7128-0_12 · Cited by 17
Quik, M., Afar, R., AUDHYA, T. K., & Goldstein, G. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07431.x · Cited by 17
RetractedKamal, M., Arif, M., & Jawaid, T. (2017) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-016-0254-6 · Cited by 16
“…to the brain are mainly mediated by cytokines such as IL-1, IL-6, and TNF-α resulting in HPA axis and SNS activation and consequently in elevated ACTH, glucocorticoid and catecholamine levels in the periphery called as sickness response (Chrousos 1995; Dunn 1988; Dunn 2000; Sapolsky et al. 1987).”
BackgroundPituitary dysfunction in infective brain diseases
Selvan, C., Beatrice, A., & Mukhopadhyay, S. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.123546 · Cited by 16
The Role of Chicken Prolactin, Growth Hormone and Their Receptors in the Immune System
Mo, G., Hu, B., Wei, P., Luo, Q., & Zhang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.900041 · Cited by 21
Ongaro, L., Castrogiovanni, D. C., Giovambattista, A., Gaillard, R. C., & Spinedi, E. (2011) · NeuroImmunoModulation · doi:10.1159/000324125 · Cited by 16
Milton, N. G. N., Self, C. H., & Hillhouse, E. W. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13535.x · Cited by 16
Deak, T. (2008) · Endocrinology · doi:10.1210/en.2008-0170 · Cited by 16
Cytokines and glucocorticoid receptors are associated with the antidepressant-like effect of alarin
Zhuang, F., Zhou, X. P., Gao, X., Lou, D. W., Bi, X., Qin, S.-J., Sun, C., Ye, P., Wang, Y., Ma, T., et al. (2016) · Peptides · doi:10.1016/j.peptides.2016.01.002 · Cited by 17
An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypes
Futch, H. S., McFarland, K. N., Moore, B. D., Kuhn, M. Z., Giasson, B. I., Ladd, T. B., Scott, K. A., Shapiro, M. R., Nosacka, R. L., Goodwin, M. S., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190430 · Cited by 20
“…monoclonals exhibited varying degrees of HPA axis suppression; however, those studies were quite limited and not translatable (Linton et al., 1985; Sapolsky et al., 1987; Giuffre et al., 1988; van Oers et al., 1989; Milton et al., 1990; Potter et al., 1992; Pich et al., 1993; Kravchenko and…”
De-Fraja, C., Conti, L., Magrassi, L., Govoni, S., & Cattaneo, E. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981101)54:3<320::aid-jnr3>3.0.co;2-r · Cited by 111
A Molecular Basis for Intersystem Communication Between the Immune and Neuroendocrine Systems
Carr, D. J. J., & Blalock, J. E. (1989) · International Reviews of Immunology · doi:10.3109/08830188909054419 · Cited by 16
Larrick, J. W., & Wright, S. C. (1992) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(11)80012-0 · Cited by 17
Hydroxyurea Induces the Gene Expression and Synthesis of Proinflammatory Cytokines In Vivo
Navarra, P., Grohmann, U., Nocentini, G., Tringali, G., Puccetti, P., Riccardi, C., & Preziosi, P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36391-8 · Cited by 16
Cytokine changes in the postoperative period
Shenkin, A. (1994) · Proceedings of The Nutrition Society · doi:10.1079/pns19940019 · Cited by 16
Raber, J., & Bloom, F. E. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00517-x · Cited by 16
Introduction: Overview of the Conference and the Field
Sternberg, E. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09543.x · Cited by 18
Brain interleukin-1 receptors: mapping, characterization and modulation
Haour, F., BAN, E., Marquette, C., Milon, G., & Fillion, G. (1992) · Elsevier eBooks · doi:10.1016/b978-0-08-041996-1.50006-6 · Cited by 16
Bluthé, R.-M., & Dantzer, R. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90162-q · Cited by 16
Interleukin-1, Interleukin-6: Messengers in the Neuroendocrine Immune System?
Hooghe-Peters, E. L., Velkeniers, B., Vanhaelst, L., & Hooghe, R. J. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80158-5 · Cited by 16
Immunologic and tissue culture approaches to the neurobiology of aging
Rpgers, J., & Rovigatti, U. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80143-x · Cited by 18
Grundy, R. I., Rothwell, N. J., & Allan, S. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01377-3 · Cited by 16
Wong, M., Alshekhlee, A., Gold, P. W., & Licinio, J. (1996) · Neuroscience intelligence unit · doi:10.1007/978-1-4615-9695-0_2 · Cited by 16
Haour, F., Marquette, C., Tsiang, H., Ban, E., Crumeyrolle‐Arias, M., Rostène, W. H., & Fillion, G. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb23116.x · Cited by 16
Inflammation Through a Psychoneuroimmunological Lens
Bennett, J. M., Gillie, B. L., Lindgren, M. E., Fagundes, C. P., & Kiecolt-Glaser, J. K. (2013) · Handbook of Systems and Complexity in Health · doi:10.1007/978-1-4614-4998-0_19 · Cited by 15
NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity
Chen, C., Zhang, S., Sheng, M., & Shao, W. (2025) · Mediators of Inflammation · doi:10.1155/mi/4330574 · Cited by 18
“IL-1 β is a pivotal activator of the HPA axis [165, 166].”
The core inflammatory factors in patients with major depressive disorder: a network analysis
Zeng, Y., Sun, B., Zhang, F., Hu, Z., Li, W., Lan, X., Ning, Y., & Zhou, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1216583 · Cited by 17
“After experiencing repeated social defeat (RSD), the mouse immune system stimulates the HPA FIGURE 2 (A) Network estimate of overall patients.”
BackgroundInfluentialCancer fatigue: a review for psychiatrists
Levy, M. R. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.01.004 · Cited by 16
“Studies have demonstrated the induction of CRH from the hypothalamus generated by cytokines IL-1 and IL-6 [56,57].”
BackgroundSerrats, J., & Sawchenko, P. E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.06.004 · Cited by 16
“…(LPS or endotoxin), a component of the Gram-negative bacterial cell wall, or cytokines themselves, to model the activation of the innate immune system (Elmquist and Saper, 1996; Elmquist et al., 1996; Ericsson et al., 1997; Rivest, 2001; Sapolsky et al., 1987; Schiltz and Sawchenko, 2002).”
BackgroundNovel action of pituitary urocortin 2 in the regulation of expression and secretion of gonadotropins
Nemoto, T., Yamauchi, N., & Shibasaki, T. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0467 · Cited by 15
Golyshkin, D., Kobyliak, N. M., Virchenko, O., Falalyeyeva, T. M., Beregova, T. V., Остапченко, Л. І., Čaprnda, M., Skladaný, Ľ., Opatřilová, R., Rodrigo, L., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.060 · Cited by 15
Walker, D. J., Zimmer, C., Larriva, M., Healy, S. D., & Spencer, K. A. (2019) · Journal of Experimental Biology · doi:10.1242/jeb.187039 · Cited by 15
“, 1998), where both cytokines function to enhance glucocorticoid production downstream of the hypothalamus and pituitary gland (Sapolsky et al., 1987).”
BackgroundEnhanced Immune Sensitivity to Stress Following Chronic Morphine Exposure
Ballard, K. A., Pellegrino, T. C., Alonzo, N. C., Nugent, A. L., & Bayer, B. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9008-9 · Cited by 16
“fectively activate the HPA axis and thus is considered a systemic stressor (Sapolsky et al. 1987; Besedovsky et al. 1991; Dunn et al. 1999; Anisman et al. 2001).”
Psychosocial Correlates of Incidence of Attacks in Children with Familial Mediterranean Fever
Gidron, Y., Berkovitch, M., & Press, J. (2003) · Journal of Behavioral Medicine · doi:10.1023/a:1023038504481 · Cited by 15
“…in which stress and negative emotions are associated with elevation of proinflammatory cytokines (e.g., Ackerman et al., 1998; Maes et al., 1998), that may in turn, induce hormonal changes in the central nervous system and lead to the elevation of fever (Oka et al., 2001; Sapolsky et al., 1987).”
BackgroundEffects of interleukin-1β on the renin-angiotensin-aldosterone system in rats
Andreis, P. G., Neri, G., Meneghelli, V., Mazzocchi, G., & Nussdorfer, G. G. (1992) · Research in Experimental Medicine · doi:10.1007/bf02576251 · Cited by 15
Stress and the Reproductive System
Li, X.-F., & O’Byrne, K. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00036-3 · Cited by 17
Corticotropin releasing hormone CRH in normal and pregnant uterus physiological implications
Gravanis, A. (1996) · Frontiers in bioscience · doi:10.2741/a137 · Cited by 20
“It is now known that IL-1 and PGE2 are major inducers of CRH expression in human placenta and rat hypothalamus (59,60).”
BackgroundThe Effects of Stress on Autoimmune Disease
Whitacre, C. C., Cummings, S. O., & Griffin, A. C. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-285960-1.50008-3 · Cited by 19
Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome
Miyasaki, Y., Goetz, M. B., & Newton, T. F. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00103-0 · Cited by 15
Cytokines in AIDS-Associated Nervous and Immune System Dysfunction
Merrill, J. E., & Martínez-Maza, O. (1993) · Methods in neurosciences · doi:10.1016/s1043-9471(13)70019-3 · Cited by 15
Makrigiannakis, A., Psychoyos, A., Zoumakis, E., Margioris, A. N., Stournaras, C., & Gravanis, A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52135.x · Cited by 15
Lin, T., Guo, H., CALKINS, J. H., Wang, D., & Chi, R. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90124-b · Cited by 15
Central neuroregulation of hypothalamic corticotrolin — releasing hormone (CRH-41) secretion
Tsagarakis, S., & Grossman, A. B. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349619 · Cited by 15
Inhibition of serotonin-induced Ca2+ mobilization by interleukin-1β in rat C6BU-1 glioma cells
Kugaya, A., Kagaya, A., Uchitomi, Y., Motohashi, N., & Yamawaki, S. (1995) · Brain Research · doi:10.1016/0006-8993(95)00345-q · Cited by 15
Givalois, L., Siaud, P., Mekaouche, M., IXART, G., Malaval, F., ASSENMACHER, I., & Barbanel, G. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815011 · Cited by 15
Investigation of the effect of interleukin-1β on steroidogenesis in the human fetal adrenal gland
Harlin, C. A., & Parker, C. R. (1991) · Steroids · doi:10.1016/0039-128x(91)90127-h · Cited by 15
Panic disorder. A long-term treatment study: fluoxetine vs imipramine
Amore, M., Magnani, K., Cerisoli, M., Casagrande, C., & Ferrari, G. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199908)14:6<429::aid-hup108>3.0.co;2-3 · Cited by 17
Regulation of interleukin‐1 receptors on AtT‐20 mouse pituitary tumour cells
Kobayashi, H., Fukata, J., Tominaga, T., Murakami, N., Fukushima, M., Ebisui, O., Segawa, H., Nakai, Y., & Imura, H. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80031-b · Cited by 15
Marquette, C., Ceccaldi, P., Ban, E., Weber, P., Tsiang, H., & Haour, F. (1996) · Archives of Virology · doi:10.1007/bf01718318 · Cited by 15
Sirivelu, M. P., MohanKumar, P. S., & MohanKumar, S. M. J. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.09.004 · Cited by 14
“IL-1β activates the HPA axis by stimulating CRH neurons, increasing CRH secretion from the hypothalamus, adrenocorticotropin (ACTH) from the pituitary, culminating in an increase in corticosterone secretion from the adrenal gland [2, 5, 15, 16].”
BackgroundMiralles, R. S., Hodge, R., & Kotecha, S. (2007) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2006.110130 · Cited by 16
Brain Cytokines as Integrators of the Immune–Neuroendocrine Network
Besedovsky, H. O., & del Rey, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30398-7_1 · Cited by 16
“CRH was the first hypothalamic releasing factor whose production was shown to be affected by a cytokine (Berkenbosch et al., 1987; Sapolsky et al., 1987; Uehara et al., 1987).”
BackgroundMechanisms of Behavioral and Neuroendocrine Effects of Interleukin‐1 in Mice
Neveu, P. J., & Liège, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05382.x · Cited by 15
Metadata
- Authors
- Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W.
- Affiliations
- Stanford University (US)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1987-10-23
- Volume
- 238
- Issue
- 4826
- Pages
- 522-524
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000956334
- Semantic Scholar
- 14be7c589804c3bf2e11a4366624c13fb4f3cefd
- Cited by
- 1,504
- References
- 22
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 9 · 2023: 11 · 2022: 13 · 2021: 12 · 2020: 14 · 2019: 11 · 2018: 15 · 2017: 12 · 2016: 23 · 2015: 17 · 2014: 17 · 2013: 18 · 2012: 23
- FWCI
- 31.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2p01am026741-06)
- National Institute on Alcohol Abuse and Alcoholism (AA-06420)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- interleukin-1, corticotropin-releasing factor, hypothalamus, glucocorticoid secretion, neuroendocrine stress response, immunoneutralization, infection, pyrogenic effect, hypothalamic hormones
- MeSH terms
- Adrenal Cortex, Adrenocorticotropic Hormone, Animals, Cell Line, Corticosterone, Corticotropin-Releasing Hormone, Hypothalamus, Immunologic Techniques, Interleukin-1, Male, Pituitary Gland, Anterior, Pituitary Neoplasms, Rats, Inbred Strains, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.